India to Iraq: Regorafenib Export Trade Route
India has recorded 15 verified shipments of Regorafenib exported to Iraq, representing a combined trade value of $18.6K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $1.2K USD. The leading Indian exporter is RMPL PHARMA LLP, which accounts for 39% of total export value with 1 shipments worth $7.3K USD. On the buying side, NA is the largest importer in Iraq with $7.3K USD in purchases. The top 3 suppliers — RMPL PHARMA LLP, SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED, RAVI PHARMA — together control 89% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Iraq Regorafenib corridor is one of India's established pharmaceutical export routes, with 15 shipments documented worth a combined $18.6K USD. The route is dominated by RMPL PHARMA LLP, which alone accounts for roughly 39% of all export value, reflecting the consolidated nature of India's regorafenib manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with regorafenib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 11.3%, placing it at rank #10 among India's top regorafenib export destinations globally.
On the import side, key buyers of Indian regorafenib in Iraq include NA, SKIN LINE LOGISTIC, ZMC EXPRESS CARGO FZCO and 2 others. NA is the single largest importer with 1 shipments valued at $7.3K USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#10
- Annual growth+11.3%
- Demand growth+10.1%
- Regulatory ease72/100
Top 10 Indian Regorafenib Exporters to Iraq
Showing top 10 of 5 Indian suppliers exporting Regorafenib to Iraq, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RMPL PHARMA LLP Avg $7.3K per shipment | 1 | $7.3K | 39.3% |
| 2 | SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED Avg $981 per shipment | 6 | $5.9K | 31.6% |
| 3 | RAVI PHARMA Avg $578 per shipment | 6 | $3.5K | 18.6% |
| 4 | INTHERA PHARMAMED BIOTECH PRIVATE LIMITED Avg $1.2K per shipment | 1 | $1.2K | 6.3% |
| 5 | ZEAL PHARMA Avg $783 per shipment | 1 | $783 | 4.2% |
This table shows the top 10 of 5 Indian companies exporting regorafenib to Iraq, ranked by total trade value. The listed exporters are: RMPL PHARMA LLP, SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED, RAVI PHARMA, INTHERA PHARMAMED BIOTECH PRIVATE LIMITED, ZEAL PHARMA. RMPL PHARMA LLP is the dominant supplier with 1 shipments worth $7.3K USD, giving it a 39% market share. The top 3 suppliers together account for 89% of the total trade value on this route.
Top 10 Regorafenib Importers in Iraq
Showing top 10 of 5 known buyers in Iraq receiving Regorafenib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian regorafenib in Iraq include NA, SKIN LINE LOGISTIC, ZMC EXPRESS CARGO FZCO, ATLAS TRADING COMPANY, TO THE ORDER OF. The largest importer is NA, accounting for $7.3K USD across 1 shipments — representing 39% of all regorafenib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NA | 1 | $7.3K | 39.3% |
| 2 | SKIN LINE LOGISTIC | 7 | $4.6K | 24.9% |
| 3 | ZMC EXPRESS CARGO FZCO | 2 | $4.3K | 23.0% |
| 4 | ATLAS TRADING COMPANY | 4 | $1.6K | 8.6% |
| 5 | TO THE ORDER OF | 1 | $783 | 4.2% |
Top 10 Regorafenib Formulations Imported by Iraq
Showing top 10 of 9 product formulations shipped on the India to Iraq Regorafenib route, ranked by trade value
Iraq imports a wide range of regorafenib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — NUBLEXA 40MG REGORAFENIB COO:GERMANY — accounts for $7.3K USD across 1 shipments. A total of 9 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NUBLEXA 40MG REGORAFENIB COO:GERMANY | 1 | $7.3K | 39.3% |
| 2 | REGONAT 40MG TAB.REGORAFENIB TABLETS 40MG (1*28 TAB.) AS PER INVOICE | 2 | $4.3K | 23.0% |
| 3 | REGONAT TAB.REGORAFENIB TABLETS 40MG1*28 TAB. AS PER DOCUMENT | 5 | $3.1K | 16.8% |
| 4 | REGONAT TAB.REGORAFENIB TABLETS 40MG(1*28 TAB.) AS PER INVOICE | 1 | $1.2K | 6.3% |
| 5 | REGONATREGORAFENIB TAB 40MG 1 28 TABS AS PER INVOICE | 1 | $826 | 4.4% |
| 6 | REGONAT 40 MG TABLET (REGORAFENIB 40 MG) | 1 | $783 | 4.2% |
| 7 | ADGORIFREGORAFENIB TAB 40MG 1 28TAB AS PER INVOICE | 1 | $439 | 2.4% |
| 8 | REGONAT 40MG REGORAFENIB TABLETS 40MG(1*28 TAB.) AS PER INVOICENOS | 1 | $337 | 1.8% |
| 9 | REGONAT 40REGORAFENIB TAB 40MG 1 28 AS PER INVOICE | 2 | $335 | 1.8% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 7 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's regorafenib exports to Iraq are driven primarily by a handful of large-scale manufacturers. RMPL PHARMA LLP with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Iraq benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — RMPL PHARMA LLP, SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED, RAVI PHARMA — together account for 89% of total trade value on this route. The average shipment value of $1.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as regonat 40mg tab.regorafenib tablets 40mg (1*28 tab.) as per invoice and regonat tab.regorafenib tablets 40mg1*28 tab. as per document , suggesting that buyers in Iraq tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NA is the largest importer with 1 shipments worth $7.3K USD — representing 39% of all regorafenib imports from India on this route.
Route Statistics
- Trade Volume
- $18.6K
- Avg. Shipment
- $1.2K
- Suppliers
- 5
- Buyers
- 5
- Transit (Sea)
- ~33 days
- Annual Growth
- +11.3%
Related Analysis
Other Regorafenib Routes
Unlock the Full India to Iraq Regorafenib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 15 shipments on this route.
Frequently Asked Questions — India to Iraq Regorafenib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Regorafenib to Iraq?
The leading Indian exporters of Regorafenib to Iraq are RMPL PHARMA LLP, SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED, RAVI PHARMA. RMPL PHARMA LLP holds the largest market share at approximately 39% of total trade value on this route.
Q What is the total value of Regorafenib exports from India to Iraq?
India exports Regorafenib to Iraq worth approximately $18.6K USD across 15 recorded shipments. The average value per shipment is $1.2K USD.
Q Which ports does India use to ship Regorafenib to Iraq?
The most active port of origin is DELHI AIR with 7 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to Iraq for Regorafenib?
The average transit time for Regorafenib shipments from India to Iraq is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Iraq Regorafenib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 11.3% with demand growth tracking at 10.1%. The route is ranked #10 among India's top Regorafenib export destinations globally.
Q How many suppliers are active on the India to Iraq Regorafenib route?
There are currently 5 active Indian suppliers exporting Regorafenib to Iraq. The market is moderately concentrated with RMPL PHARMA LLP accounting for 39% of total shipment value.
Q Who are the main importers of Regorafenib from India in Iraq?
The leading importers of Indian Regorafenib in Iraq include NA, SKIN LINE LOGISTIC, ZMC EXPRESS CARGO FZCO, ATLAS TRADING COMPANY, TO THE ORDER OF. NA is the largest buyer with 1 shipments worth $7.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Iraq export trade corridor identified from Indian Customs (DGFT) records for Regorafenib.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 5 importers in Iraq matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 15 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists